Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ROYALTY PHARMA PLC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 3.1M shares of RPRX (ROYALTY PHARMA PLC), worth $120.5M as of 2025-Q4. The position was decreased (-0.3% shares). RPRX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$120.5M
Current Shares
3.1M
Total Value Change
+$46.7M
Total Shares Change
+321,538
Other major holders of RPRX: ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY
Decreased |
| 3.1M |
-0.3% |
| $120.5M |
| 0.0% |
| $38.99 |
0 |
| 2025-Q3 | Decreased | 3.1M | -23.2% | $110.4M | 0.0% | $35.05 | 0 |
| 2025-Q2 | Increased | 4.1M | +43.2% | $146.9M | 0.0% | $35.46 | 41 |
| 2025-Q1 | Increased | 2.8M | +8.6% | $88.7M | 0.0% | $30.80 | 32 |
| 2024-Q4 | Decreased | 2.6M | -11.8% | $66.9M | 0.0% | $24.70 | 0 |
| 2024-Q3 | Increased | 3M | +6.3% | $84.1M | 0.0% | $27.29 | 32 |
| 2024-Q2 | Increased | 2.8M | +50.1% | $73.8M | 0.0% | $25.32 | 41 |